title: Primary psammocarcinoma of the ovary or peritoneum.
abstract: BACKGROUND
  The aim of this study was to assess the outcomes of patients treated for peritoneal or ovarian psammocarcinoma (PSC).
  
  
  METHODS
  Review of patients with PSC who underwent cytoreductive surgery in our institution with a follow-up of more than 18 months (the ovarian or peritoneal tumor was histologically reviewed by our reference pathologist).
  
  
  RESULTS
  From 1997 to 2006, 15 patients with PSC were histologically reviewed in our institution. Five of these patients fulfilled the inclusion criteria. Four patients had ovarian PSC, and 1 had peritoneal PSC. Four patients were surgically treated during initial management and another patient at the time of recurrence. All of them underwent complete cytoreductive surgery followed by intraperitoneal chemotherapy in 2 patients and by conventional adjuvant chemotherapy in 1. After a median follow-up of 42 months, 4 of them remain disease-free.
  
  
  CONCLUSIONS
  Peritoneal or ovarian PSC is a rare low-grade carcinoma characterized by a more favorable prognosis than classic carcinoma. The place of debulking surgery at the time of initial or recurrent management is important.
authors: Institut Gustave-Roussy, Villejuif, France.
authors: Olivier
authors: O
authors: Poujade
authors: Catherine
authors: C
authors: Uzan
authors: Sebastien
authors: S
authors: Gouy
authors: Patricia
authors: P
authors: Pautier
authors: Pierre
authors: P
authors: Duvillard
authors: Philippe
authors: P
authors: Morice
mesh_terms: D000328:Adult; D000368:Aged; D018284:Cystadenocarcinoma, Serous / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000473:pathology / Q000601:surgery*; D010534:Peritoneal Neoplasms / Q000473:pathology / Q000601:surgery*; D016896:Treatment Outcome; D055815:Young Adult